Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Verista Partners With INCOG BioPharma Services for Verista 360° Managed Service Program

PR Newswire June 8, 2021

NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects

PR Newswire June 8, 2021

Integral Molecular Expands Partnership with Japan's Life Sciences Distributor Funakoshi to Provide Access to Antibody Specificity and Epitope Mapping Services

PR Newswire June 8, 2021

BioAgilytix Holds Ribbon Cutting To Celebrate Boston Lab Expansion, Additional Jobs And Tech Capabilities

PR Newswire June 8, 2021

Progentec Announces Research Collaboration with GSK to Assess Proteomics and Digital Health Tools for Lupus (SLE) Care

PR Newswire June 8, 2021

Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

PR Newswire June 8, 2021

PathAI to Present Machine Learning-based Quality Control Tool for HER2 Testing in Breast Cancer at the American Society of Clinical Oncology Virtual Scientific Program 2021

PR Newswire June 8, 2021

EOSERA Informs on Benefits of Nasal Rinsing with New Product: NOSE WELL(TM)

PR Newswire June 8, 2021

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

PR Newswire June 8, 2021

Cardiff Oncology Announces First Patient Dosed in a Phase 2 Trial of Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic Cancer

PR Newswire June 8, 2021

AIVITA Biomedical's Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival

PR Newswire June 8, 2021

Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study

PR Newswire June 8, 2021

TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei's efficacy at an unprecedented level in weight loss and satiety

Canada NewsWire June 8, 2021

CARISMA Therapeutics Appoints Richard Morris as Chief Financial Officer

PR Newswire June 8, 2021

OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway

PR Newswire June 8, 2021

MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as President and CEO

PR Newswire June 8, 2021

Compugen Announces Updated Data from Phase 1 Study of COM701, First- in-Class Anti-PVRIG, at the ASCO 2021 Annual Meeting

PR Newswire June 8, 2021

ViaCyte Appoints Dr. Evert Kroon as Interim Chief Scientific Officer

PR Newswire June 8, 2021

Innoforce Pharmaceuticals to Participate in BIO International Digital Convention

PR Newswire June 8, 2021

Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium

PR Newswire June 8, 2021